Test predicts if breast cancer chemotherapy...( Reston Virginia -- Resistance to chemo...),Health

Reston, Virginia -- Resistance to chemotherapy is a major cause of treatment failure in patients with breast cancer. A study reported in the June issue of The Journal of Nuclear Medicine found that scintigraphic imaging with 99mTc-sestamibi accurately predicted which breast tumors would be chemoresistant.

The study was able to predict 100% of the time which patients would respond to chemotherapy, and 83% of the time which patients would not respond. Physicians in this phase II clinical trial studied 30 patients with untreated locally advanced breast cancer for whom a cycle of chemotherapy followed by surgery was planned. The patients received an injection of 99mTc-sestamibi and were scanned before treatment and again before surgery.

Those who were likely to respond had a low wash-out rate, or WOR (<45%) of the 99mTc-sestamibi. That means a higher amount of it remained in the body after injection, and showed up in the scan. Those unlikely to respond had a higher WOR (>45%). The authors pointed out that knowing a tumor was likely to be chemoresistant would allow physicians to prescribe specific drugs to boost the bodys ability to respond to chemotherapy.

Results of the first test were analyzed to determine the amount of radiotracer uptake in the tumor at 10 minutes and 240 minutes, and the washout rate was calculated. The second scan was used diagnostically to confirm tumor response to treatment and the pretherapy therapy result. Results were also confirmed pathologically by the subsequent surgery. Scintigraphy is an imaging technique that uses radioisotopes and a gamma camera.

'"/>

Contact: Karen Lubieniecki
karenlub@aol.com
703-683-0357
Society of Nuclear Medicine
3-Jun-2002

Page: 1
Related medicine news :

1. New evaluation tool reliably predicts recovery from coma
2. New scale predicts recovery of consciousness from coma after brain injury
3. Computational tool predicts how drugs work in cells, advancing efforts to design better medicines
4. Depression predicts heart rhythm abnormalities in heart attack patients
5. A shallow hip socket predicts osteoarthritis of the hip
6. Molecule predicts colon cancer patient survival
7. Substance in urine predicts development of preeclampsia
8. Blood protein predicts risk of heart attack
9. Molecular test predicts risk of breast cancer recurrence and who will benefit from chemotherapy
10. New molecular classification of breast cancer predicts response to chemotherapy
11. Family history predicts young womens risk of stroke